Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]
Malakar S, Giri S, Jena A, Nath P.
europepmc +1 more source
Janus kinase inhibitors in giant cell arteritis: unmet needs and new challenges. [PDF]
Gkouvi A +3 more
europepmc +1 more source
Concomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis. [PDF]
Tursi A +11 more
europepmc +1 more source
Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases. [PDF]
Dai R, Lou N, Zheng X, Han X.
europepmc +1 more source
Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]
Ahsan MU +5 more
europepmc +1 more source
Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead? [PDF]
Jung YS.
europepmc +1 more source
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate. [PDF]
Yoon J +5 more
europepmc +1 more source
Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review. [PDF]
Moschella A, DeBiasio C, Liy-Wong C.
europepmc +1 more source
The use of Janus kinase inhibitors to treat noninfectious uveitis. [PDF]
Beckman M +5 more
europepmc +1 more source
Selective Janus kinase inhibitors exhibit different effects in murine immune aplastic anemia. [PDF]
Durrani J +10 more
europepmc +1 more source

